Explore Our Comprehensive Pharmaceuticals Industry Research Reports
P
2022
The global analgesics market was valued at $26.7 billion in 2020, and is projected to reach $50.7 billion by 2030, growing at a CAGR of 6.6% from 2021 to 2030.
Report Code : A01063 | Pages : 133 | Category : Life Sciences
U
2024
There are a large number of people using opioid medication as painkillers. As per the statistics by the United Nations Office on Drugs and Crime, almost 26.4 to ...
Report Code : A03274 | Category : Life Sciences
P
2022
The global opioid use disorder market was valued at $2.8 billion in 2021, and is projected to reach $8.1 billion by 2031, growing at a CAGR of 11.5% from 2022 to 2031.
Report Code : A12303 | Pages : 324 | Category : Life Sciences
P
2023
The global opioid induced constipation (OIC) drugs market was valued at $1.1 billion in 2021, and is projected to reach $1.8 billion by 2031, growing at a CAGR of 4.9% from 2022 to 2031.
Report Code : A13376 | Pages : 359 | Category : Life Sciences
P
2022
The North America Aneurysmal Subarachnoid Hemorrhage Drugs Market is expected to grow lucratively over the forecast period. In addition, it covers qualitative analysis on the basis of several parameters, including impact on market size, economic impact, regulatory framework, opportunity window, and key player strategies.
Report Code : A24847 | Category : Life Sciences
P
2022
Drug Class segment is projected to create abundant revenue opportunity till 2030. Leading players in Mexico Aneurysmal Subarachnoid Hemorrhage Drugs Market are profiled in the report, providing insights on their key strategies, overview and product offerings in the market.
Report Code : A24848 | Category : Life Sciences
P
2022
U.S. Aneurysmal Subarachnoid Hemorrhage Drugs Market is projected to experience high investment on various major technologies/product/services in U.S. country by the end of 2030 owing to presence of key end user vertical adopting offerings at a faster pace.
Report Code : A24849 | Category : Life Sciences
P
2022
The Canada Aneurysmal Subarachnoid Hemorrhage Drugs Market is segmented into season type, rim size, vehicle type, and distribution channel. The Canada Aneurysmal Subarachnoid Hemorrhage Drugs Market growth is attributed to various driving factors and opportunities.
Report Code : A24850 | Category : Life Sciences
P
2022
The Europe Aneurysmal Subarachnoid Hemorrhage Drugs Market is segmented based on drug class. Depending on Drug Class segment, the Other Drugs sub-segment is expected to register significant CAGR during the forecast period.
Report Code : A24851 | Category : Life Sciences
P
2022
The Germany Aneurysmal Subarachnoid Hemorrhage Drugs Market achieved significant revenue share in base year of analysis. The Germany Aneurysmal Subarachnoid Hemorrhage Drugs Market size is expected to account for a considerable growth rate between 2021 to 2030.
Report Code : A24852 | Category : Life Sciences
Register and Earn 500 Loyalty Points
An Email Verification Code has been sent to your email address!
Please check your inbox and, if you don't find it there, also look in your junk folder.